It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006.
In the Conclusions section the final sentence should read:
Questions such as the optimal duration of therapy and efficacy in stage I disease remain to be answered.
References
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Research. 2006, 8: R13-10.1186/bcr1384.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/bcr1384
Rights and permissions
About this article
Cite this article
Powles, T., Paterson, A., McCloskey, E. et al. Erratum to: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 8, 406 (2006). https://doi.org/10.1186/bcr1413
Published:
DOI: https://doi.org/10.1186/bcr1413